Trial intelligence / Profile preview

Passiflora incarnata and Isoflavone for Climacteric Symptoms

NCT01695616Phase 3Withdrawn

Sponsor
Aché Laboratórios Farmacêuticos
Start
Aug 2013
Primary completion
Aug 2014
Modality
HM (Herbal Medicine), NHE (Natural Herbal Extract)
Countries
1
01

Overview

A Phase 3 trial of passiflora incarnata, glycine max extract in climacteric syndrome, sponsored by Aché Laboratórios Farmacêuticos. Planned start Aug 2013; status: withdrawn.

02

Drugs

passiflora incarnataglycine max extract
03

Conditions

climacteric syndrome

Beyond the preview

Go deeper on NCT01695616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01695616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call